Alkem Laboratories Ltd reports US FDA inspection of Mandva API facility concluded with no Form 483 observations
- Inspection ran from 26–30 October 2026.
- Facility manufactures active pharmaceutical ingredients (APIs).
Alkem Laboratories US FDA Inspection Update
This is an automated summary of a public document. Always check the original before relying on it.